Cagrilintide is a long-acting agonist of amylin and calcitonin receptors in late phase trials for obesity. Here, authors present structures of cagilintide with each target receptor, revealing the molecular basis for its non-selective action.
- Jianjun Cao
- Matthew J. Belousoff
- Patrick M. Sexton
